Are Insurance Companies Finally Warming Up to GLP-1s?

For a while, trying to get your insurance to cover a GLP-1 medication (like Ozempic, Wegovy, Mounjaro, or Zepbound) felt kind of like asking a vending machine for a refund. You could push every button, fill out every form, call every number, and still walk away empty-handed.

Insurance companies have put in quite a bit of effort to make these medications difficult to access, even when they’re clearly medically necessary. But a shift has begun and an increasing number of people are getting approvals by their insurance company for GLP-1 agonists. But it is not just luck. Getting approved requires strategy, timing, and knowing exactly where to look - and that’s where Katherine can help. I will back up and explain.

Insurers Are Starting to Budge

Nowadays, the science around GLP-1s is impossible to ignore. Medications like semaglutide and tirzepatide don’t just help with balancing blood sugar or weight, they’ve been shown to reduce the risk of heart attacks, strokes, and complications from sleep apnea and insulin resistance, making them medically relevant to a large percent of the population.

That kind of data gets insurance companies' attention, not because they suddenly care, but because it saves them money down the line. So now, some plans are opening coverage under specific conditions: cardiovascular disease, sleep apnea, pre-diabetes with high BMI, and more. But make no mistake—they’re not advertising it. They’re not going to call you up and say, “Hey, you qualify now!” In fact, they’re still hoping you’ll give up.

What’s more, behind the scenes, large companies have started asking insurers to cover GLP-1s as part of broader wellness initiatives. Some are even funding it themselves because healthier employees miss fewer days and stay more productive.

But again, these benefits often come with fine print, hidden requirements, and hoops to jump through. Even with broader medical recognition and employer pressure, getting approved is still a maze of prior authorizations, diagnosis codes, appeals, re-authorizations, “step therapy” requirements—it’s confusing on purpose. The process isn’t about fairness. And unless you know how to navigate every twist and turn, you’re likely to hit a wall. Unless you have Katherine to hold your hand.

How Katherine Cary Can Help

Here’s the truth: most people shouldn’t have to become insurance experts just to get the care they need. And with Katherine, you don’t have to.

We do it all—the paperwork, the benefits investigation, the back-and-forth with insurers, the clinical documentation, even the follow-ups months down the line. All you do is fill out a simple questionnaire and ee handle the rest. Our expert medical team knows where insurers hide the loopholes and how to use your medical history to make the strongest case for coverage.

So, If You Were Denied Before, We Invite You Try Again

Coverage policies have changed and new doors have opened. And you don’t need to fight this alone or waste time on dead ends. GLP-1s are not about chasing trends. They’re real medications for real conditions—and more people deserve access to them. The system isn’t suddenly working. But we at Katherine have learned how to work around it.